Actualités Prothena Corp. Plc - Ordinary Shares (MM) - PRTAV | Actions NASDAQ

Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022

Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022 DUBLIN, Ireland...

Prothena to Participate in JMP Securities Hematology and Oncology Summit

Prothena to Participate in JMP Securities Hematology and Oncology Summit DUBLIN, Ireland, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Prothena...

Prothena Reports Third Quarter 2021 Financial Results and Business Highlights

Prothena Reports Third Quarter 2021 Financial Results and Business Highlights Net cash provided by operating and investing activities was...

Prothena to Report Third Quarter 2021 Financial Results on November 4th

Prothena to Report Third Quarter 2021 Financial Results on November 4th DUBLIN, Ireland, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Prothena...

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) DUBLIN, Ireland, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Prothena...

Prothena Announces Executive Appointments

Prothena Announces Executive Appointments Expanded roles support the continued transition to a fully integrated biotechnology company focused...

Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DUBLIN, Ireland, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Prothena...

Prothena to Participate in Upcoming September Healthcare Conferences

Prothena to Participate in Upcoming September Healthcare Conferences DUBLIN, Ireland, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Prothena...

Prothena Reports Second Quarter 2021 Financial Results and Business Highlights

Prothena Reports Second Quarter 2021 Financial Results and Business Highlights Net cash provided by operating and investing activities was...

Prothena to Report Second Quarter 2021 Financial Results on August 5th

Prothena to Report Second Quarter 2021 Financial Results on August 5th DUBLIN, Ireland, July 29, 2021 (GLOBE NEWSWIRE) -- Prothena...

Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021

Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021 Late-breaking...

Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Confer...

Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Conference 2021 DUBLIN...

Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme

Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme Prothena is eligible to receive...

Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and ...

Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and Development...

Prothena to Participate in JMP Securities Life Sciences Conference on June 16

Prothena to Participate in JMP Securities Life Sciences Conference on June 16 DUBLIN, Ireland, June 10, 2021 (GLOBE NEWSWIRE) -- Prothena...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV)

Votre Hub pour des idées et discussions en direct en temps réel

PRTAV Actualités

Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022

Prothena to Participate in JMP Securities Hematology and Oncology Summit

Prothena Reports Third Quarter 2021 Financial Results and Business Highlights

Prothena to Report Third Quarter 2021 Financial Results on November 4th

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Prothena Announces Executive Appointments

Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Prothena to Participate in Upcoming September Healthcare Conferences

Prothena Reports Second Quarter 2021 Financial Results and Business Highlights

Prothena to Report Second Quarter 2021 Financial Results on August 5th

Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021

Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Confer...

Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme

Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and ...

Prothena to Participate in JMP Securities Life Sciences Conference on June 16

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV) Actualités

Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV)

Votre Hub pour des idées et discussions en direct en temps réel

PRTAV Actualités

Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022

Prothena to Participate in JMP Securities Hematology and Oncology Summit

Prothena Reports Third Quarter 2021 Financial Results and Business Highlights

Prothena to Report Third Quarter 2021 Financial Results on November 4th

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Prothena Announces Executive Appointments

Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Prothena to Participate in Upcoming September Healthcare Conferences

Prothena Reports Second Quarter 2021 Financial Results and Business Highlights

Prothena to Report Second Quarter 2021 Financial Results on August 5th

Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021

Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Confer...

Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme

Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and ...

Prothena to Participate in JMP Securities Life Sciences Conference on June 16

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application